CAV1 and non-small cell lung carcinoma: After decreasing the expression of CAV1, the inhibitory role of LINC81507 in NSCLC progression is reversed, suggesting that upregulation of CAV1 by LINC81507 contributes to the tumor suppressor role of LINC81507 in NSCLC.